Checkpoint Capital L.P.
13F Reported Value
ⓘ$278.7M
Holdings
8
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Checkpoint Capital L.P. disclosed 8 positions worth $278.7M in its Form 13F-HR for Q1 2026, led by $ARGX (ARGENX SE) at 40.1% of the equity portfolio, followed by $RYTM and $RVMD. During the quarter the fund opened 3 new positions and exited 2 — including a new stake in $SEPN and a full exit from $CORT. The portfolio is most concentrated in Healthcare (100.0% of disclosed assets). All figures are sourced directly from Checkpoint Capital L.P.’s Form 13F-HR filing with the SEC under CIK 1977548.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$111.7M153,000 sh - 30.3#2,364
Quality
$106.7M1,227,200 sh - —
Quality
$25.5M262,539 sh - —
Quality
$18.3M286,661 sh - 28.0
Quality
$11.9M180,000 sh - 44.6
Quality
$2.4M100,300 sh - 26.5
Quality
$1.5M40,230 sh - —
Quality
$596.5K50,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 ARGENX SE$ARGX | — | $111.7M | 153,000 |
 RHYTHM PHARMACEUTICALS, INC.$RYTM | 30.3#2,364 | $106.7M | 1,227,200 |
 Revolution Medicines, Inc.$RVMD | — | $25.5M | 262,539 |
 Disc Medicine, Inc.$IRON | — | $18.3M | 286,661 |
 CYTOKINETICS INC$CYTK | 28.0 | $11.9M | 180,000 |
 Septerna, Inc.$SEPN | 44.6 | $2.4M | 100,300 |
 Crinetics Pharmaceuticals, Inc.$CRNX | 26.5 | $1.5M | 40,230 |
 Trevi Therapeutics, Inc.$TRVI | — | $596.5K | 50,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Checkpoint Capital L.P.'s 8 positions.
Showing top 8 of 8 holdings.
Sector Allocation
Healthcare
$278.7M
Full Holdings — Checkpoint Capital L.P. (Q1 2026)
All 8 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $ARGX | ARGENX SE | $111.7M | 40.1% | +8% | — |
| 2 | $RYTM | RHYTHM PHARMACEUTICALS, INC. | $106.7M | 38.3% | +24% | 30.3 |
| 3 | $RVMD | Revolution Medicines, Inc. | $25.5M | 9.2% | -29% | — |
| 4 | $IRON | Disc Medicine, Inc. | $18.3M | 6.6% | -37% | — |
| 5 | $CYTK | CYTOKINETICS INC | $11.9M | 4.3% | +8% | 28 |
| 6 | $SEPN | Septerna, Inc. | $2.4M | 0.9% | NEW | 44.6 |
| 7 | $CRNX | Crinetics Pharmaceuticals, Inc. | $1.5M | 0.5% | NEW | 26.5 |
| 8 | $TRVI | Trevi Therapeutics, Inc. | $596,500 | 0.2% | NEW | — |
New Positions (3)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Checkpoint Capital L.P. including:
Track Checkpoint Capital L.P.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Checkpoint Capital L.P. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Checkpoint Capital L.P.
13F Pro is an AI hedge fund tracker and stock research platform. For Checkpoint Capital L.P. (SEC CIK: 1977548), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Checkpoint Capital L.P.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.